1 min read

A Virus That Kills Shrimp Is Showing Up in Human Eyes

A seafood pathogen has turned up in the eye tissue of patients with a serious, vision-threatening condition.

So there's a virus. It normally kills shrimp. It's called covert mortality nodavirus (CMNV). Previously, it was considered strictly an aquatic animal problem — the kind of thing that devastates shrimp farms, not something that has any business being in a human body.

And yet. Researchers in China studying a mysterious and growing eye condition found CMNV in the eye tissue of every single patient they tested. Seventy people. All of them positive. The virus matched its aquatic strain at nearly 99%. Most patients had handled raw seafood or eaten raw aquatic animals without protection. When scientists infected mice with the same virus, the mice developed the same eye symptoms: inflammation, dangerously high pressure inside the eye, damage to the optic nerve. In some human cases: permanent vision loss.

This is the first time a virus from aquatic animals has been linked to a specific human disease. Ever.

CMNV has now been found in 49 species across Asia, Africa, Europe, the Americas, and Antarctica. It infects invertebrates, fish, and apparently mammals. University of Sydney virologist Edward Holmes called its host range "quite remarkable" and said he couldn't imagine another virus with such breadth. There is also preliminary evidence, not yet confirmed, of human-to-human transmission.

Why does it go for the eyes? Nobody knows. The researchers aren't sure how it gets from a shrimp to an eyeball, or why that specific destination. That question is still open.

A shrimp virus. In human eyes. On every continent. Cause unknown.

Read the full story at New Scientist, April 1, 2026


Hot Take: We've been sharing the planet with a virus that jumps from invertebrates to fish to mammals and ends up in human eyes, and only just noticed. That's either a triumph of modern genomics or a very uncomfortable reminder of how much we're not watching.

Subscribe to our newsletter.

Be the first to know - subscribe today